Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 2:12:832747.
doi: 10.3389/fonc.2022.832747. eCollection 2022.

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment

Harun Ilhan  1 , Trevor Royce  2   3 , Xuefeng Qiu  4 , Constantinos Zamboglou  5   6
Affiliations
Editorial

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment

Harun Ilhan et al. Front Oncol. .
No abstract available

Keywords: personalized and precision medicine (PPM); prostate cancer; prostate specific membrane antigen (PSMA); radiotherapy; surgery.

PubMed Disclaimer

Conflict of interest statement

Authors TR was employed by Flatiron Health. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment

References

    1. Rawla P. Epidemiology of Prostate Cancer. World J Oncol (2019) 10(2):63–89. doi: 10.14740/wjon1191 - DOI - PMC - PubMed
    1. Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, et al. . Intraprostatic Tumor Segmentation on PSMA PET Images in Patients With Primary Prostate Cancer With a Convolutional Neural Network. J Nucl Med (2021) 62(6):823–8. doi: 10.2967/jnumed.120.254623 - DOI - PMC - PubMed
    1. Bravaccini S, Puccetti M, Bocchini M, Ravaioli S, Celli M, Scarpi E, et al. . PSMA Expression: A Potential Ally for the Pathologist in Prostate Cancer Diagnosis. Sci Rep (2018) 8(1):4254. doi: 10.1038/s41598-018-22594-1 - DOI - PMC - PubMed
    1. Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. . Prostate-Specific Membrane Antigen PET-CT in Patients With High-Risk Prostate Cancer Before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study. Lancet (2020) 395(10231):1208–16. doi: 10.1016/S0140-6736(20)30314-7 - DOI - PubMed
    1. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, et al. . Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol (2019) 5(6):856–63. doi: 10.1001/jamaoncol.2019.0096 - DOI - PMC - PubMed

Publication types